Showing 877–888 of 1432 results

  • Motil Fast 10 Sachets

    Motil Fast 10 Sachets

    0 out of 5
    EGP26

    Product Name: Motil Fast 10 Sachets Product Type:Prokinetic Agent / Gastrointestinal Motility Enhancer Description:Motil Fast is a powdered oral formulation designed to improve gastrointestinal motility, helping food pass through the stomach and intestines more efficiently. It is commonly used to relieve symptoms of bloating, nausea, and delayed gastric emptying. Active Ingredient (per sachet): Usually contains…

  • Motinorm Suspension 125 ml

    Motinorm Suspension 125 ml

    0 out of 5
    EGP31

    Motinorm Suspension 125ml Form: Oral suspension Volume: 125ml Use: Treatment of nausea, vomiting, and gastrointestinal motility disorders Indications:• Nausea and vomiting• Delayed gastric emptying• Gastroesophageal reflux symptoms under medical supervision Key Components: Prokinetic agent (exact active ingredient may vary by manufacturer) Dosage: Use as directed by a healthcare professional; shake well before use; measure with…

  • Mounjaro 10mg\0.6ml 1 Kwikpen

    Mounjaro 10mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP15,455

    Mounjaro 10 mg/0.6 ml (1 KwikPen) Active Ingredient: Tirzepatide 10 mg per 0.6 ml prefilled injection pen Therapeutic Class:Dual GIP and GLP-1 receptor agonist – Antidiabetic and weight management medication Indications: Type 2 diabetes mellitus in adults to improve blood glucose control: As monotherapy when metformin is not tolerated or contraindicated. Or in combination with…

  • Mounjaro 12.5mg\0.6ml 1 Kwikpen

    Mounjaro 12.5mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP18,150

    Mounjaro 12.5 mg/0.6 ml (1 KwikPen) Active Ingredient: Tirzepatide 12.5 mg per 0.6 ml prefilled pen Therapeutic Class:Dual GIP and GLP-1 receptor agonist (antidiabetic and weight management agent) Indications: Type 2 diabetes mellitus in adults to improve blood glucose control: As monotherapy (if metformin is not suitable) Or in combination therapy with other antidiabetic medications…

  • Mounjaro 15mg\0.6ml 1 Kwikpen

    Mounjaro 15mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP18,150

    Mounjaro 15 mg / 0.6 ml (1 KwikPen) Active Ingredient: Tirzepatide 15 mg per 0.6 ml – Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Pharmaceutical Form: Pre-filled injection pen (KwikPen) for subcutaneous use. Therapeutic Class: Antidiabetic and weight management medication. Indications: Type 2 diabetes mellitus in adults to improve glycemic control,…

  • Mounjaro 2.5mg\0.6ml 1 Kwikpen

    Mounjaro 2.5mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP9,435

    Medication Name: Mounjaro 2.5mg/0.6ml 1 KwikPenActive Ingredient: Tirzepatide 2.5 mg per 0.6 ml injection Pharmacological Class: Dual GIP and GLP-1 receptor agonist (antidiabetic / weight-management agent) Indications: Type 2 diabetes mellitus (adjunct to diet and exercise) Sometimes used off-label for weight management in adults with obesity or overweight with related conditions Dosage Form: Prefilled pen…

  • Mounjaro 5mg\0.6ml 1 Kwikpen

    Mounjaro 5mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP12,250

    Medication Name: Mounjaro 5mg/0.6ml 1 KwikPenActive Ingredient: Tirzepatide 5 mg per 0.6 ml injection Pharmacological Class: Dual GIP and GLP-1 receptor agonist (antidiabetic/weight management agent) Indications: Type 2 diabetes mellitus (as adjunct to diet and exercise) Sometimes prescribed off-label for weight reduction in adults with obesity or overweight with comorbidities Dosage Form: Prefilled pen (subcutaneous…

  • Mounjaro 7.5mg\0.6ml 1 Kwikpen

    Mounjaro 7.5mg\0.6ml 1 Kwikpen

    0 out of 5
    EGP15,455

    Mounjaro 7.5 mg/0.6 ml (1 KwikPen) Active Ingredient: Tirzepatide 7.5 mg per 0.6 ml prefilled pen Therapeutic Class:Dual GIP and GLP-1 receptor agonist (antidiabetic and weight management agent) Indications: Type 2 diabetes mellitus in adults to improve glycemic control: As monotherapy when metformin is not tolerated or contraindicated. In combination with other antidiabetic agents such…

  • Moventor 20 Capsules

    Moventor 20 Capsules

    0 out of 5
    EGP390

    Moventor 20 Capsules Description:A dietary supplement formulated to support metabolic health and provide antioxidant support through a combination of nutrients that may assist in overall wellbeing. Indications:Support for metabolic processes, energy metabolism, and antioxidant protection when dietary intake may be insufficient. Key Components (per capsule):Typically includes a blend of nutrients and plant-derived compounds known to…

  • Moxiflox 400mg 10 Tablets

    Moxiflox 400mg 10 Tablets

    0 out of 5
    EGP180

    Medication Name: Moxiflox 400 mg Tablets (10 Tablets)Active Ingredient: Moxifloxacin 400 mg Pharmacologic Class: Fluoroquinolone antibiotic Indications: Community-acquired pneumonia and acute bacterial sinusitis. Acute exacerbation of chronic bronchitis. Skin and soft tissue infections. Intra-abdominal infections caused by susceptible bacteria. Pelvic inflammatory disease (mild to moderate cases). Dosage and Administration: Adults: 400 mg once daily, taken…

  • Moxiflox Eye Drops 5ml

    Moxiflox Eye Drops 5ml

    0 out of 5
    EGP33

    Moxiflox Eye Drops 5ml Active IngredientsMoxifloxacin hydrochloride 0.5% w/v IndicationsUsed for: Treatment of bacterial eye infections such as conjunctivitis Relief of redness, swelling, and discharge caused by susceptible bacteria DosageAdults and children (over 1 year): Instill 1–2 drops into the affected eye(s) every 2–4 hours for the first 2 days, then 1–2 drops every 4–8…

  • Mucobrav 600mg 10 Sachets

    Mucobrav 600mg 10 Sachets

    0 out of 5
    EGP75

    Product Type:Mucolytic agent (effervescent granules for oral solution) Active Ingredient:Acetylcistein 600 mg per sachet Indications: Relief of productive cough associated with respiratory tract diseases (bronchitis, COPD, pneumonia) Helps liquefy and clear thick mucus in the airways May be used as an adjuvant in cystic fibrosis or chronic bronchopulmonary disorders Also used as a supportive therapy…

End of content

End of content